bay-i 9139 has been researched along with thiabendazole in 1 studies
| Studies (bay-i 9139) | Trials (bay-i 9139) | Recent Studies (post-2010) (bay-i 9139) | Studies (thiabendazole) | Trials (thiabendazole) | Recent Studies (post-2010) (thiabendazole) |
|---|---|---|---|---|---|
| 13 | 0 | 0 | 1,939 | 44 | 213 |
| Protein | Taxonomy | bay-i 9139 (IC50) | thiabendazole (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.8 | |
| Methionine aminopeptidase | Escherichia coli K-12 | 0.472 | |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 0.472 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gugnani, HC; Okeke, CN | 1 |
1 other study(ies) available for bay-i 9139 and thiabendazole
| Article | Year |
|---|---|
In vitro sensitivity of environmental isolates of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-morpholine derivative.
Topics: Animals; Antifungal Agents; Culture Media; Econazole; Fungi; Imidazoles; Ketoconazole; Mice; Miconazole; Microbial Sensitivity Tests; Morpholines; Thiabendazole; Triazoles | 1987 |